US EditionPublished • loading... • Updated
98% of the Drugs Blocked: This Brain Lock that a French Biotech Wants to Blow Up
Summary by latribune.fr
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
An innovation of rupture in neurodegenerative diseases: Harmonix develops a focused ultrasonic solution to treat Alzheimer and Parkinson. The Orléanian start-up has just been selected by the Servier laboratory to integrate its Paris Saclay incubator. It aims to market its solution by 2028. Explanations.
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
